| Identification | Back Directory | [Name]
L-Serine, N-(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)-, hydrazide | [CAS]
156074-08-7 | [Synonyms]
L-Serine, N-(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)-, hydrazide | [Molecular Formula]
C17H15N3O5 | [MDL Number]
MFCD00924121 | [MOL File]
156074-08-7.mol | [Molecular Weight]
341.32 |
| Hazard Information | Back Directory | [Description]
NU/ICRF 500 is a novel anthracenyl-amino acid topoisomerase II catalytic inhibitor. | [Uses]
NU/ICRF 500 is a topo II catalytic inhibitor which increases CREST negative micronuclei in human lymphocytes[1]. | [References]
[1] Cummings J, et al. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500. Mutat Res. 1995 Aug;344(1-2):55-62. DOI:10.1016/0165-1218(95)90038-1 |
|
|